<DOC>
	<DOCNO>NCT00504309</DOCNO>
	<brief_summary>The purpose study evaluate cardiovascular lipid effect two dos omega-3 fatty acid concentrate group people normally treat high lipid .</brief_summary>
	<brief_title>Vascular Lipid Effects Omega-3 Fatty Acids People With Moderately Elevated Triglycerides</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>triglyceride 150500 mg/dL age 2165 generally healthy BMI 2039 smoking premenopausal ( female ) use hormone replacement oral contraceptive use lipid lower blood pressure medication hypertension ( BP &gt; 150/95 ) peripheral vascular disease heart disease , diabetes , stroke inflammatory disease ( e.g . rheumatoid arthritis crohn 's ) elevate liver enzymes high intake omega3 contain food allergy adhesive latex use aspirin , anticoagulant , SSRI</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>triglyceride</keyword>
	<keyword>hypertriglyceridemia</keyword>
	<keyword>omega-3</keyword>
	<keyword>n-3</keyword>
	<keyword>eicosapentaenoic acid</keyword>
	<keyword>EPA</keyword>
	<keyword>docosahexaenoic acid</keyword>
	<keyword>DHA</keyword>
	<keyword>flow mediate dilation</keyword>
	<keyword>fish</keyword>
	<keyword>Moderate hypertriglyceridemia</keyword>
</DOC>